Detailed analysis and meaningful insight from industry experts.
Now that Q1 2019 is in the books and public companies have completed their filings, our analysts have taken a deeper look at what those results mean for the months ahead.
Cannabis-focused private equity and venture funds have already announced plans to raise more than $1.2 billion this year – and they’re doing their best to attract investors.
In this issue, Harvest Health’s acquisition of Verano Holding’s represents an interesting exercise in how cannabis company’s are valuated – and sets the tone for more M&A activity to come. Also in this issue: how cannabis retailers compare to mainstream with regards to revenue per square foot, key investment concerns in the cannabis industry and Tilray’s bullish outlook for global expansion.
In this issue, we examine which sectors have lost their luster – and where investors may want to look instead. Also in this issue: tips for valuing marijuana and hemp companies for strategic acquisitions or investments, an assessment of the Ohio market and an update on Colorado’s rules against public investment.
In this issue, Cresco Labs’ CEO Charlie Bachtell shares why he considers market penetration – not retail footprint – to be a stronger strategy for the company. Also in this issue: a deeper look at how two Canadian cannabis titans are growing outside North America, tips for getting into investing in this industry and a snapshot of retail opportunities.
